ViiV Healthcare

GSK-Backed ViiV Healthcare’s Cabenuva Outperforms Daily Oral HIV Therapy In Adherence-Challenged Patients

GSK-Backed ViiV Healthcare’s Cabenuva Outperforms Daily Oral HIV Therapy In Adherence-Challenged Patients

12 hours ago

3 min read

GSK and ViiV Healthcare Announce £6 Million Commitment to Strengthen Community-Led Fight Against HIV, TB and Malaria

Policy & Public Health

GSK and ViiV Healthcare Announce £6 Million Commitment to Strengthen Community-Led Fight Against HIV, TB and Malaria

21 Oct 2025

2 min read

ViiV Healthcare and Medicines Patent Pool extends voluntary licensing agreement to enable access to long-acting injectable HIV treatment

ViiV Healthcare and Medicines Patent Pool extends voluntary licensing agreement to enable access to long-acting injectable HIV treatment

15 Jul 2025

3 min read

Read More

Voice Of HealthCare

vohnetwork.com